Simulations Plus (SLP)

• Market cap: $638M
• 1 day: -0.22%
• 5 days: -14.96%
• 1 month: 0.35%
• 3 months: 5.76%
• 6 months: -15.19%
• Year to date: 13.83%
• 1 year: -22.89%
• 5 years: -18.14%
• 10 years: 409.13%
• Sector: Information Technology
• Industry: Computer Integrated Systems Design

About: Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Employees: 247

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

93% more call options, than puts

Call options by funds: $393K | Put options by funds: $204K

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

1.58% more ownership

Funds ownership: 77.29% [Q3] → 78.86% (+1.58%) [Q4]

4% less funds holding

Funds holding: 169 [Q3] → 163 (-6) [Q4]

11% less capital invested

Capital invested by funds: $495M [Q3] → $442M (-$53.1M) [Q4]

13% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 31

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $35 10% upside
• Avg. target: $36 13% upside
• High target: $37 16% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Keybanc Brett Fishbin 50% 1-year accuracy 9 / 18 met price target	16% upside $37	Overweight Maintained	24 Jan 2025
Keybanc Scott Schoenhaus 67% 1-year accuracy 24 / 36 met price target	10% upside $35	Overweight Maintained	8 Jan 2025